Fiserv Inc

FISV

Market cap $35.9B

Bragar Eagel & Squire, P.C.  Litigation Partner  Brandon Walker  Encourages Investors Who Suffered Losses In Fiserv (FISV) To Contact Him Directly To Discuss Their Options

Despite pockets of earnings strength across the financials sector, the broader 2026 backdrop remains challenging. Sticky inflation, elevated asset valuations, regulatory uncertainty, and shifting investor sentiment have narrowed the margin for error, even for well-established companies. As seen with Fiserv's abrupt selloff last quarter, downside risk can materialize quickly when high expectations are not met.

Alphabet was the top contributor during the quarter. Its stock price jumped after it delivered impressive third-quarter earnings. Fiserv was the top detractor during the quarter. Its stock price declined sharply after reporting disappointing third-quarter earnings. Amrize is a leading producer of building materials and construction solutions, established following Holcim's spin-off of its North American operations in June.

At the start of 2025, the stock market appeared unstable as most major assets were, seemingly, very overvalued. Despite this, there was no shortage of opportunities for savvy investors to find undervalued, cheap stocks that enabled them to turn a $1,000 into $10,000 of profit.

MOORPARK, Calif.--(BUSINESS WIRE)--100GROUP earned the 2025 Fiserv/CardConnect Circle of Excellence Award, recognizing its leadership in integrated payments, software, and service.

We believe Fiserv (FISV) stock is worth examining: It is growing, generating cash, and is available at a considerable valuation discount. Companies like this can utilize cash to stimulate further revenue growth, or simply return value to their shareholders through dividends or buybacks.

Health and wellness providers who use Clover devices can now offer their patients CareCredit's patient financing solution. The offering is enabled by an expanded integration of CareCredit parent company Synchrony with Clover, which is an all-in-one commerce solution from Fiserv, the companies said in a Monday (Jan. 12) press release.

Integration on Clover devices now reaches over 40,000 health and wellness providers, streamlining patient applications and payments at the point of sale  Key Highlights: Enables all providers who use Clover devices to facilitate CareCredit applications and process transactions at the point of sale -- helping them scale their financial processes to drive business growth. CareCredit is the first and only patient financing solution available on the Clover App Market.

Fiserv shares have overreacted to Q3 2025 guidance and management changes, presenting a patient buy opportunity. Current valuations price in excessive pessimism, assuming permanently impaired margins and low single-digit growth, which my DCF analysis finds unlikely. Core assets remain resilient: Clover GPV grows double digits, client attrition is minimal, and free cash flow guidance is unchanged despite reinvestment.

Fiserv has launched a new analytics capability designed to help merchants and their marketing partners better understand in-store customers. The new Unknown Shopper solution transforms payment data into actionable insights by enriching it with demographic information, the global provider of payments and financial services technology said in a Friday (Jan. 9) press release.